Menu Search
Equities

Shanghai Shenqi Pharmaceutical Investment Management Co Ltd

900904:SHH

Shanghai Shenqi Pharmaceutical Investment Management Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)0.462
  • Today's Change0.015 / 3.36%
  • Shares traded285.36k
  • 1 Year change-24.39%
  • Beta--
Data delayed at least 15 minutes, as of Jul 30 2024 08:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Shanghai Shenqi Pharmaceutical Investment Management Co.,Ltd. is a China-based company principally engaged in research and development, manufacture and sale of pharmaceuticals. The Company’s products are targeted for the treatment of influenza, cardio cerebrovascular diseases, rheumatoid bone diseases and in the areas of oncology, antifungal, antipyretic and gynaecology. The Company's main products include cantharidin sodium vitamin B6 injection, cantharidin sodium injection and other Chinese patent drug products. The Company distributes its products in domestic market.

  • Revenue in CNY (TTM)2.33bn
  • Net income in CNY57.15m
  • Incorporated1992
  • Employees1.43k
  • Location
    Shanghai Shenqi Pharmaceutical Investment Management Co LtdRoom 613Changfa Tower, No. 128, Weihai RoadSHANGHAI 200003ChinaCHN
  • Phone+86 2 153750009
  • Fax+86 2 153750010
  • Websitehttp://www.gzsq.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.